FMH James M Stockman Cancer Institute — Frederick, Maryland

FMH James M Stockman Cancer Institute is a clinical research site located in Frederick, Maryland, United States 21702.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

FMH James M Stockman Cancer Institute has participated in 18 clinical trials with 15 currently active.

Therapeutic areas: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma.

Sponsors: National Cancer Institute (NCI), NRG Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Frederick

Browse all research sites in Maryland · View every site in Frederick

• Frederick Memorial Hospital Fred. Mem. Hosp.
• [Site 13] Frederick Memorial Hospital d/b/a James M Stockman Cancer Institute
• Frederick Memorial Hospital Regional Cancer Therapy Center
• Frederick Memorial Hospital
• Frederick Health Hospital- James M Stockman Cancer Institute
• Frederick Memorial Hospital Dept. of FMH-IRB
• Frederick Memorial Hospital Cancer Center
• Frederick Memorial Hospital, Regional Cancer Center
• Frederick Health Hospital
• University of Maryland at The Pediatric Center of Frederick Site Number : 8400004
• Frederick Memorial Hospital Crestwood
• Research Site

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for FMH James M Stockman Cancer Institute?

FMH James M Stockman Cancer Institute has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has FMH James M Stockman Cancer Institute conducted?

FMH James M Stockman Cancer Institute has 18 clinical trials on record, with 15 currently active. Their work covers Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma.

Is FMH James M Stockman Cancer Institute accredited by Crixeo Clinical Trials?

FMH James M Stockman Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about FMH James M Stockman Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.